戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e assay) and prednisone administered via the jejunostomy.
2 eral nutrition and decompression by means of jejunostomy.
3 y and 17 of 21 (81%) for replacement feeding jejunostomy.
4 undoplication or insertion of a transgastric jejunostomy.
5 stric pouch (4), gastric remnant (2), jejuno-jejunostomy (1), Roux limb (1), and cervical esophagus (
6                    Surgical anatomy included jejunostomy (47%), jejunocolic (39%), and ileocolic anas
7 cess rate was 19 of 20 (95%) for new feeding jejunostomy and 17 of 21 (81%) for replacement feeding j
8                                            A jejunostomy and a Bishop-Koop ileostomy were constructed
9 as nutritional autonomy after removal of the jejunostomy and tracheotomy tubes.
10 as nutritional autonomy after removal of the jejunostomy and tracheotomy tubes.
11 e jejunal necrosis required bowel resection, jejunostomy, and ileostomy.
12                              Gastrostomy and jejunostomy can be successfully placed using endoscopic
13 d complication rates of feeding percutaneous jejunostomy compare favorably with those of surgery or e
14   In general, direct percutaneous endoscopic jejunostomy (DPEJ) is becoming a more common procedure p
15                                              Jejunostomy facilitated drainage, dilation, stone extrac
16  procedure with and without post-anastomosis jejunostomy feeding tube (JFT).
17                                              Jejunostomy feeding tube shows a beneficial effect on th
18                                Conversion to jejunostomy feedings is suggested for neurologically imp
19 pically (grade IIIa = 72%), whereas hepatico-jejunostomy (grade IIIb) was performed in 22%.
20         In older patients, the presence of a jejunostomy (hazard ratios [HR]: 3.4; 95% CI: 1.1, 10.6)
21 eral support volume, bowel anatomy (group 1, jejunostomy/ileostomy; group 2, >/=50% colon-in-continui
22                                 Percutaneous jejunostomy is a useful and underused approach to managi
23 tube insertion (ie, gastrostomy, gastrostomy-jejunostomy, or jejunostomy tube), as identified by Onta
24 tion, appendectomy, splenectomy, gastrostomy/jejunostomy, orchidopexy, and cholecystectomy (P < .05)
25 ecurrence of symptoms and had a transgastric jejunostomy performed.
26 d outcomes of direct percutaneous endoscopic jejunostomy placement.
27 enteroscopy techniques provide more reliable jejunostomy placement.
28       Two patients who underwent replacement jejunostomy required laparotomy for possible leakage; th
29                          All patients with a jejunostomy required long-term PN.
30 antages and disadvantages of gastrostomy and jejunostomy techniques.
31      Eight of 9 patients no longer relied on jejunostomy tube feeding, and no adverse events were not
32 tube removal, alvimopan usage, and judicious jejunostomy tube feeding, or total parenteral nutrition
33 ent resection and were randomized to IEF via jejunostomy tube or control (CNTL).
34 nausea and abdominal distention 3 days after jejunostomy tube placement and initiation of jejunal ent
35 ie, gastrostomy, gastrostomy-jejunostomy, or jejunostomy tube), as identified by Ontario Health Insur
36 evelopment of direct percutaneous endoscopic jejunostomy tubes for patients at high risk of aspiratio
37 y (5 days orally), and postoperatively via a jejunostomy until 1 month postdischarge.
38                         A new or replacement jejunostomy was created for alimentation in 20 and 21 pa
39                                              Jejunostomy was performed for interventional procedures
40                                 Percutaneous jejunostomy was performed in 62 patients, most of whom h